Research shows the antipsychotic drug aripiprazole—sold under the brand name Abilify and less commonly as Aripiprex—causes strokes and hyperglycemia.
The Rottenstein Law Group compassionately advocates for those who have suffered from side effects as a result of having taken dangerous drugs. If you’ve taken Abilify and believe it harmed you, contact RLG for a free, confidential legal consultation immediately. We will evaluate your case and remain on the lookout for Abilify recalls and Abilify class action lawsuits. We might be the Abilify law firm you’re looking for.
What Is Abilify and What Is It Prescribed For?
Abilify is the brand name for the drug aripiprazole. Made and sold by the U.S. pharmaceutical company Bristol-Myers Squibb, this prescription medication is used to treat schizophrenia, bipolar disorder, and clinical depression. Abilify was first developed by the Japanese pharmaceutical company Otsuka. The U.S. Food and Drug Administration (FDA) approved it in 2002 for the treatment of schizophrenia, in 2004 for the treatment of bipolar disorder, and in 2007 for for the treatment of major depressive disorder.
As an atypical antipsychotic, Abilify blocks dopamine receptors in the brain. It differs pharmacologically from similar drugs, and it’s less likely than some antipsychotic drugs to cause involuntary body movements.
Controversies have eroded consumer confidence in Abilify. In 2007, Bristol-Myers Squibb settled an Abilify lawsuit brought by whistleblowers and the Department of Justice to the tune of $515 million. To encourage doctors to prescribe Abilify, Bristol-Myers Squibb was paying them kickbacks in the form of consulting fees and paid luxury vacations.
Abilify Might Cause Life-Threatening Side Effects
Elderly patients with dementia sometimes suffer strokes (transient ischemic attacks) when taking Abilify. The FDA has not approved Abilify for the treatment of dementia in the elderly. There is a black box Abilify warning on the product’s label informing users that that the drug carries an increased risk of death in elderly users. Like many antidepressants, the drug also carries a black box suicide warning for users under the age of 24. Also, the “pregnancy” section of Abilify’s label now informs doctors and women who were about to become pregnant that Abilify causes withdrawal symptoms in infants in the form of abnormal muscle movements (called extrapyramidal signs (EPS)). The FDA required Bristol-Myers Squibb to make that change in February 2011.
Like other atypical antipsychotic drugs, there is concern that aripiprazole causes metabolic disorders, particularly hyperglycemia (excess sugar) and diabetes. Atypical antipsychotics cause the body to metabolize fat instead of carbohydrates, leading to insulin resistance to the excess carbohydrates. At the same time they promote fat accumulation.
The attorneys at the Rottenstein Law Group are on the lookout for Abilify recalls and class action lawsuits against Bristol-Myers Squibb.
RLG’s Lawyers Will Make Things Easier
The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file an Abilify lawsuit on your behalf if necessary. RLG will also keep you up to date on any Abilify class action lawsuits, FDA Abilify warnings and Abilify FDA recall announcements.
If you have taken Abilify and believe it harmed you, contact RLG today.